100 related articles for article (PubMed ID: 8629373)
1. [The significance of tumor suppressor genes and viral oncoproteins in the onset of malignant cell transformation].
Bojić I; Malesević M
Vojnosanit Pregl; 1995; 52(4):371-6. PubMed ID: 8629373
[No Abstract] [Full Text] [Related]
2. Adenovirus E1a as a tumor-suppressor gene.
Chinnadurai G
Oncogene; 1992 Jul; 7(7):1255-8. PubMed ID: 1535700
[TBL] [Abstract][Full Text] [Related]
3. The human papillomavirus E6 protein and its contribution to malignant progression.
Mantovani F; Banks L
Oncogene; 2001 Nov; 20(54):7874-87. PubMed ID: 11753670
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the cell cycle by viral oncoproteins.
Vousden KH
Semin Cancer Biol; 1995 Apr; 6(2):109-16. PubMed ID: 7647307
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of virus-induced carcinogenesis: the interaction of viral factors with cellular tumor suppressor proteins.
Hoppe-Seyler F; Butz K
J Mol Med (Berl); 1995 Nov; 73(11):529-38. PubMed ID: 8751137
[TBL] [Abstract][Full Text] [Related]
6. [Protein P53, protector of genome integrity: its role in carcinogenesis].
Bellahcene A; Merville MP; Gielen J; Lambotte R; Simar L; Castronovo V
Rev Med Liege; 1994 May; 49(5):274-84. PubMed ID: 8023054
[No Abstract] [Full Text] [Related]
7. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein.
Münger K; Basile JR; Duensing S; Eichten A; Gonzalez SL; Grace M; Zacny VL
Oncogene; 2001 Nov; 20(54):7888-98. PubMed ID: 11753671
[TBL] [Abstract][Full Text] [Related]
8. The p53 tumor suppressor gene and gene product.
Levine AJ
Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
[TBL] [Abstract][Full Text] [Related]
9. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
[TBL] [Abstract][Full Text] [Related]
10. Defining the mechanisms of transformation through analysis of revertant cells.
Bassin RH; Benade LE
Immunol Ser; 1990; 51():15-47. PubMed ID: 2095917
[No Abstract] [Full Text] [Related]
11. Interactions between papillomavirus proteins and tumor suppressor gene products.
Vousden KH
Adv Cancer Res; 1994; 64():1-24. PubMed ID: 7879655
[No Abstract] [Full Text] [Related]
12. Oncogenes and their mechanisms of action.
Găldean D
Roum Arch Microbiol Immunol; 1992; 51(1-2):75-99. PubMed ID: 1457825
[No Abstract] [Full Text] [Related]
13. Regulated expression of retroviruses and their oncogenes: models for tumor suppression.
Wyke J; Poole CJ
Immunol Ser; 1990; 51():49-73. PubMed ID: 1965702
[No Abstract] [Full Text] [Related]
14. Role of protein-tyrosine kinases in cellular transformation.
Varticovski L
Sangre (Barc); 1991 Aug; 36(4):305-9. PubMed ID: 1663662
[No Abstract] [Full Text] [Related]
15. Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein.
Yew PR; Berk AJ
Nature; 1992 May; 357(6373):82-5. PubMed ID: 1533443
[TBL] [Abstract][Full Text] [Related]
16. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.
Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM
Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886
[TBL] [Abstract][Full Text] [Related]
17. The interaction between p53 and papillomaviruses.
Mantovani F; Banks L
Semin Cancer Biol; 1999 Dec; 9(6):387-95. PubMed ID: 10712885
[TBL] [Abstract][Full Text] [Related]
18. [Interaction of viral transforming gene products and tumor suppressor gene products].
Sawada Y; Yamashita T; Fujinaga K
Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1618-25. PubMed ID: 9279089
[No Abstract] [Full Text] [Related]
19. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation.
Raveh T; Droguett G; Horwitz MS; DePinho RA; Kimchi A
Nat Cell Biol; 2001 Jan; 3(1):1-7. PubMed ID: 11146619
[TBL] [Abstract][Full Text] [Related]
20. [Viruses and cancer: molecular pathologic mechanisms of viral carcinogenesis].
Butz K; Hoppe-Seyler F
Immun Infekt; 1995 Oct; 23(5):179-84. PubMed ID: 8530130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
